Survival among 359 873 lung cancer patients according to histological type and surgery
| 0–1 Month | 1 Month–1 Year | 1 Year + | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period of follow-up: | HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | |||
| NSCLC with surgery (29 670) | 1.00 | 1.00 | 1.00 | |||||||||
| SCLC with surgery (incidental) (267)* | 2.24 | 1.45 | 3.45 | <0.001 | 1.65 | 1.29 | 2.11 | <0.001 | 1.38 | 1.13 | 1.68 | 0.002 |
| SCLC with surgery (elective) (198)† | 0.98 | 0.46 | 2.05 | 0.949 | 1.36 | 1.00 | 1.84 | 0.050 | 1.47 | 1.18 | 1.82 | 0.001 |
| NSCLC, no surgery (284 355) | 5.59 | 5.26 | 5.94 | <0.001 | 6.76 | 6.57 | 6.96 | <0.001 | 3.30 | 3.23 | 3.37 | <0.001 |
| SCLC, no surgery (45 383) | 6.26 | 5.88 | 6.67 | <0.001 | 6.59 | 6.39 | 6.80 | <0.001 | 3.89 | 3.77 | 4.00 | <0.001 |
Mortality HR adjusted for age, sex, comorbidity and socioeconomic deprivation.
*Diagnosis 7 days or less before resection. SCLC probably diagnosed from the resection specimen.
†Resection was 8 days or longer after diagnosis. SCLC diagnosis probably known before resection.
SCLC, small cell lung cancer; NSCLC, non-small cell lung cancer.